Search

Author/Creator Shaker, M. K.

1. Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt. Issue 3 (29th November 2017)

Authors:
Omar, H.; El Akel, W.; Elbaz, T.; El Kassas, M.; Elsaeed, K.; El Shazly, H.; Said, M.; Yousif, M.; Gomaa, A. A.; Nasr, A.; AbdAllah, M.; Korany, M.; Ismail, S. A.; Shaker, M. K.; Doss, W.; Esmat, G.; Waked, I.; El Shazly, Y.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 3(2018)
Page Start:
421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care. Issue 4 (1st February 2017)

Authors:
El‐Akel, W.; El‐Sayed, M. H.; El Kassas, M.; El‐Serafy, M.; Khairy, M.; Elsaeed, K.; Kabil, K.; Hassany, M.; Shawky, A.; Yosry, A.; Shaker, M. K.; ElShazly, Y.; Waked, I.; Esmat, G.; Doss, W.
Journal:
Journal of viral hepatitis
Issue:
Volume 24:Issue 4(2017)
Page Start:
262
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗